Butterfly Network to Participate at Oppenheimer 35th Annual Healthcare MedTech & Services Virtual Conference on March 18, 2025
Butterfly Network (NYSE: BFLY), a digital health company specializing in handheld whole-body ultrasound technology, has announced its participation in the upcoming Oppenheimer 35th Annual Healthcare MedTech & Services Virtual Conference on March 18, 2025.
The company's leadership, including Joseph DeVivo (President, CEO & Chairman) and Heather Getz (EVP & Chief Financial and Operations Officer), will engage in one-on-one investor meetings and participate in a Fireside Chat scheduled for 11:20am EDT. Investors can access the Fireside Chat webcast through the Events & Presentations section of Butterfly's investor website.
Butterfly Network (NYSE: BFLY), un'azienda di salute digitale specializzata nella tecnologia di ultrasuoni portatili per tutto il corpo, ha annunciato la sua partecipazione alla prossima 35ª Conferenza Virtuale Annuale MedTech & Servizi di Oppenheimer che si terrà il 18 marzo 2025.
La leadership dell'azienda, inclusi Joseph DeVivo (Presidente, CEO e Presidente del Consiglio) e Heather Getz (EVP e Direttore Finanziario e delle Operazioni), parteciperà a incontri individuali con gli investitori e prenderà parte a un Fireside Chat programmato per le 11:20 EDT. Gli investitori possono accedere alla trasmissione in diretta del Fireside Chat attraverso la sezione Eventi & Presentazioni del sito web per investitori di Butterfly.
Butterfly Network (NYSE: BFLY), una empresa de salud digital especializada en tecnología de ultrasonido portátil para todo el cuerpo, ha anunciado su participación en la próxima 35ª Conferencia Virtual Anual de MedTech y Servicios de Oppenheimer que se llevará a cabo el 18 de marzo de 2025.
El liderazgo de la empresa, incluidos Joseph DeVivo (Presidente, CEO y Presidente del Consejo) y Heather Getz (EVP y Directora Financiera y de Operaciones), se involucrará en reuniones individuales con inversores y participará en un Fireside Chat programado para las 11:20 a.m. EDT. Los inversores pueden acceder a la transmisión del Fireside Chat a través de la sección de Eventos y Presentaciones en el sitio web para inversores de Butterfly.
버터플라이 네트워크 (NYSE: BFLY), 휴대용 전신 초음파 기술을 전문으로 하는 디지털 헬스 기업이 오펜하이머 제35회 연례 헬스케어 메드텍 및 서비스 가상 컨퍼런스에 참여한다고 발표했습니다. 이 행사는 2025년 3월 18일에 열립니다.
회사의 리더십 팀인 조셉 드비보 (회장, CEO 및 이사회 의장)와 헤더 겟츠 (EVP 및 CFO) 는 투자자와의 일대일 회의에 참석하고 동화책 대화가 EDT 기준 오전 11시 20분에 예정되어 있습니다. 투자자들은 버터플라이의 투자자 웹사이트의 이벤트 및 발표 섹션을 통해 동화책 대화 웹캐스트에 접근할 수 있습니다.
Butterfly Network (NYSE: BFLY), une entreprise de santé numérique spécialisée dans la technologie d'échographie portable pour l'ensemble du corps, a annoncé sa participation à la prochaine 35e Conférence Virtuelle Annuelle MedTech & Services d'Oppenheimer qui se tiendra le 18 mars 2025.
La direction de l'entreprise, y compris Joseph DeVivo (Président, PDG et Président du Conseil) et Heather Getz (EVP et Directrice Financière et des Opérations), participera à des réunions individuelles avec des investisseurs et prendra part à un Fireside Chat prévu à 11h20 EDT. Les investisseurs peuvent accéder à la diffusion en direct du Fireside Chat via la section Événements & Présentations du site web des investisseurs de Butterfly.
Butterfly Network (NYSE: BFLY), ein digitales Gesundheitsunternehmen, das sich auf tragbare Ultraschalltechnologie für den gesamten Körper spezialisiert hat, hat seine Teilnahme an der bevorstehenden 35. Virtuellen Jahreskonferenz für MedTech und Dienstleistungen von Oppenheimer am 18. März 2025 angekündigt.
Die Unternehmensführung, einschließlich Joseph DeVivo (Präsident, CEO und Vorsitzender) und Heather Getz (EVP und Chief Financial and Operations Officer), wird an persönlichen Investorengesprächen teilnehmen und an einem Fireside Chat teilnehmen, der für 11:20 Uhr EDT geplant ist. Investoren können über den Bereich Veranstaltungen & Präsentationen auf der Investorenseite von Butterfly auf den Fireside Chat-Webcast zugreifen.
- None.
- None.
A webcast of the Fireside Chat will be available in the Events & Presentations section of the Butterfly investor website.
To schedule a one-on-one meeting with Mr. DeVivo and Ms. Getz, please reach out to your Oppenheimer representative.
About Butterfly Network
Butterfly Network, Inc. (NYSE: BFLY) is a healthcare company driving a digital revolution in medical imaging with its proprietary Ultrasound-on-Chip™ semiconductor technology and ultrasound software solutions. In 2018, Butterfly launched the world’s first handheld, single-probe, whole-body ultrasound system, Butterfly iQ. The iQ+ followed in 2020, and the iQ3 in 2024, each with improved processing power and performance by leveraging Moore’s Law. The iQ3 earned Best Medical Technology at the 2024 Prix Galien
Butterfly combines advanced hardware, intelligent software, AI, services, and education to drive adoption of affordable, accessible imaging. Clinical publications demonstrate that its handheld ultrasound probes paired with Compass™ enterprise workflow software, can help hospital systems improve care workflows, reduce costs, and enhance provider economics. With a cloud-based solution that enables care anywhere through next-generation mobility, Butterfly aims to democratize healthcare by addressing critical global healthcare challenges. Butterfly devices are commercially available to trained healthcare practitioners in areas including, but not limited to, parts of
View source version on businesswire.com: https://www.businesswire.com/news/home/20250305818293/en/
Butterfly Investors:
Heather Getz
Chief Financial and Operations Officers, Butterfly
investors@butterflynetwork.com
or
Steve Halper
LifeSci Advisors (IR Representative)
646-876-6455
shalper@lifesciadvisors.com
Source: Butterfly Network, Inc.
FAQ
When is Butterfly Network (BFLY) presenting at the Oppenheimer Healthcare Conference 2025?
Who will represent BFLY at the Oppenheimer Healthcare Conference 2025?
How can investors access BFLY's Oppenheimer Conference presentation?